You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (19)

Journals (0)

1-10 of 19 results for advanced gastric/gastroesophageal junction cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis

Open access

Research article

First published 2023

Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis

Youwen Zhu, Kun Liu, Hong Zhu [...]

Therapeutic Advances in Gastroenterology

Select article: Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Open access

Research article

First published 2025

Cost-effectiveness analysis of Cadonilimab in first-line treatment of advanced HER2-negative gastric cancer or gastroesophageal junction cancer

Kaiqi Zhu, Mengyao Qin, Zhaoyi Pan [...]

Therapeutic Advances in Gastroenterology

Select article: Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis

Open access

Research article

First published 2024

Immune Checkpoint Inhibitor Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis

Lianghui Zhang, Lingli Huang, Zhixian Liu [...]

Technology in Cancer Research & Treatment

Select article: First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer,gastroesophageal junction cancer,and esophageal adenocarcinoma: a cost-effectiveness analysis

Open access

Research article

First published 2023

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer,gastroesophageal junction cancer,and esophageal adenocarcinoma: a cost-effectiveness analysis

Xueqiong Cao, Mingming Zhang, Na Li [...]

Therapeutic Advances in Medical Oncology

Select article: Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study

Open access

Research article

First published 2024-7

Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study

Yifan Gao, Haoqian Li, Lei Qiu [...]

Science Progress

Select article: Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma

Retricted access

Review article

First published 2017-12

Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma

Fabiana G. Curea, Mohamed Hebbar, Silvia M. Ilie [...]

Cancer Biotherapy and Radiopharmaceuticals

Select article: Expression of P53 Protein and Dna Flow Cytometry in Gastric Adenocarcinoma: Implications in Patients Treated with Adjuvant Etoposide,Adriamycin and Cisplatin

Retricted access

Other

First published 2005-7

Expression of P53 Protein and Dna Flow Cytometry in Gastric Adenocarcinoma: Implications in Patients Treated with Adjuvant Etoposide,Adriamycin and Cisplatin

Abdullah Büyükçelik, Handan Onur, Hakan Akbulut [...]

Tumori Journal

Select article: Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer

Free access

Research article

First published 2012-9

Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer

Alicia F.C. Okines, David Cunningham

Therapeutic Advances in Gastroenterology

Select article: Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

Free access

Research article

First published 2013-4

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer

Khaldoun Almhanna, Kenneth L. Meredith, Sarah E. Hoffe [...]

Cancer Control

Select article: Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Open access

Research article

First published 2021

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Hye Sook Han, Bum Jun Kim, Hee-Jung Jee [...]

Therapeutic Advances in Medical Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access